CB Insights
Technology Market Intelligence
Technology Market Intelligence
Kiromic (NASDAQ: KRBP) exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical di...Show all
Company (IPO / Went public)
Phone: 832-968-4888
7707 Fannin
Suite 140
Houston, 77054
Texas, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions and methods for treating cancers | Mar 13, 2017 | Jul 21, 2020 | Patent |
| Platform for the identification of tumor-associated cancer/testes antigens | Apr 25, 2017 | Application | |
| Human sperm fibrous sheath (fs) proteins: new target antigens for use in therapeutic cancer vaccines and diagnostic screening and methods of using same | Apr 08, 2016 | Application | |
| Compositions and methods for treating cardiovascular diseases using foxp3 | Feb 25, 2016 | Application | |
| Methods and compositions for treating malignancies with dendritic cells | May 20, 2015 | Application |
